Detection of the formation of protoporphyrin IX (PPIX) in the bladder using an endoscopic fluorescence filter system to optimize photodynamic diagnosis and therapy

Detection of the formation of protoporphyrin IX (PPIX) in the bladder using an endoscopic fluorescence filter system to optimize photodynamic diagnosis and therapy - PDDFILTER

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023931

Enrollment

Registered

2020-12-21

Start date

2021-01-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

5-573.41 C67

Interventions

Group 1: Current established standard treatment procedure for clinic of PDD on the urinary bladder: A catheter is placed in your bladder. After the bladder has been emptied, Hexvix is given in the bla

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Clear findings of bladder carcinoma under white light cystoscopy - Consent to study participation

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
By detecting CPIII and UPIII with the help of an endoscopic fluorescence filter system, the optimal diagnosis time for PDD in the urinary bladder can be determined	—

Countries

Germany

Contacts

Public ContactUwe-Bernd Liehr

Klinik für Urologie, Uroonkologie, robotergestützte und fokale Therapie

uwe-bernd.liehr@med.ovgu.de+49-391-67-15037

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026